- Supported exchanges /
- KQ /
- 308080.KQ
ViGenCell Inc. (308080 KQ) stock market data APIs
ViGenCell Inc. specializes in immune cell therapy. It develops ViTier, a T-cell therapy platform that uses antigen-specific killer T cells to target and remove cancer cells; ViRanger, a T-cell gene therapy platform that uses innate killer T cells to target and eliminate abnormal cells; and ViMedier, an immunosuppressive cell therapy platform that uses the differentiation and expansion of cord blood derived myeloid suppressor cells for universal use. The company was founded in 1995 and is based in Seoul, South Korea.
ViGenCell Inc. Financial Data Overview
| 2655 | |
| 2605 | |
| - | |
| 2655 | |
| 2560 | |
| 2560-6190 | |
| 50 664 M | |
| 19 264 K | |
| 55 000 K | |
| -160.6659 | |
| 1.044 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ViGenCell Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 55 000 K
- EBITDA -13 937 867 776
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get ViGenCell Inc. Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get ViGenCell Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
